William G. Rice Ph.D.
Net Worth

Last updated:

What is William G. Rice Ph.D. net worth?

The estimated net worth of Dr. William G. Rice Ph.D. is at least $6,519,916 as of 25 Nov 2024. He owns shares worth $105,145 as insider, has earned $1,021,791 from insider trading and has received compensation worth at least $5,392,980 in Aptose Biosciences Inc..

What is the salary of William G. Rice Ph.D.?

Dr. William G. Rice Ph.D. salary is $898,830 per year as Chairman, Pres & Chief Executive Officer in Aptose Biosciences Inc..

How old is William G. Rice Ph.D.?

Dr. William G. Rice Ph.D. is 66 years old, born in 1959.

What stocks does William G. Rice Ph.D. currently own?

As insider, Dr. William G. Rice Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Aptose Biosciences Inc. (APTO) Chairman, Pres & Chief Executive Officer 50,000 $2.1 $105,145

What does Aptose Biosciences Inc. do?

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, which is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and various non-Hodgkin's lymphomas, as well as AML and HR MDS; and APL-581, a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program. It has agreements with CrystalGenomics, Inc. and OHM Oncology. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.

APTO logo
APTO
Aptose Biosciences Inc.
$2.1

William G. Rice Ph.D. insider trading

Aptose Biosciences Inc.

Dr. William G. Rice Ph.D. has made only one insider trade between 2019-2024, according to the Form 4 filled with the SEC. He purchased 50,000 units of APTO stock worth $12,500 on 25 Nov 2024.

As of 25 Nov 2024 he still owns at least 50,000 units of APTO stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Warrants 50,000 $0.25 $12,500
Purchase
Common Shares 100,000 $0.2 $20,000
Purchase
Common Shares 10,000 $0.68 $6,830
Purchase
Common Shares 10,000 $0.97 $9,680
Purchase
Common Shares 13,183 $1.52 $20,038
Purchase
Common Shares 17,822 $1.12 $19,961
Purchase
Common Shares 8,643 $2.31 $19,965
Purchase
Common shares 6,081 N/A N/A
Sale
Common Shares 168,891 $6.05 $1,021,791
Purchase
Common Shares 3,400 $5.82 $19,802
Purchase
Common Shares 10,000 $1.92 $19,200
Purchase
Common Shares 10,000 $1.85 $18,510
Purchase
Common Shares 10,000 $1.9 $18,990